Cancer Treatment Denied in Minnesota: Appeal

Minnesota has a strong tradition of healthcare access and a world-class cancer care network that includes the Mayo Clinic Comprehensive Cancer Center in Rochester and Masonic Cancer Center at the University of Minnesota in Minneapolis. Despite this, Minnesota cancer patients face insurance denials for immunotherapy, proton therapy, genetic testing, and clinical trial participation. This guide explains your rights and how to fight back.

Minnesota's Insurance Landscape

Major insurers in Minnesota include Blue Cross and Blue Shield of Minnesota, HealthPartners, Medica, UCare, and PreferredOne. Minnesota Medical Assistance (Medicaid) expanded under the ACA and is administered through managed care plans including UCare, Hennepin Healthcare, and others. Minnesota also has MinnesotaCare — a state subsidized program for lower-income Minnesotans who do not qualify for Medical Assistance.

The Minnesota Department of Commerce (DOC) regulates fully insured commercial health plans. Self-funded employer plans fall under ERISA. MNsure is Minnesota's state ACA exchange. Minnesota has a tradition of strong consumer insurance protections enforced by the Department of Commerce.

State Protections for Cancer Patients

Clinical Trial Mandate: Minnesota Statutes Section 62A.309 requires fully insured health plans to cover routine patient care costs for enrollees participating in qualifying cancer clinical trials. Covered routine costs include physician services, laboratory tests, imaging, and supportive care. Patients enrolled in trials at Mayo Clinic or University of Minnesota Masonic Cancer Center should cite this statute if routine costs are denied.

External Independent Review: Complete Guide" class="auto-link">External Review Rights: Minnesota provides for external review by an IRO after internal appeals are exhausted. Expedited external review for urgent cancer cases must be completed within 72 hours. The Minnesota Department of Commerce administers the external review program, and IRO decisions are binding on the insurer.

Oral Chemotherapy Parity: Minnesota Statutes Section 62A.3099 requires that oral anticancer drugs be covered at the same cost-sharing level as IV chemotherapy drugs. This protection ensures that patients prescribed oral targeted therapies are not penalized financially relative to those receiving infusion treatments.

Step Therapy Protections: Minnesota law requires health plans to maintain step therapy exception processes. Oncologists can request exceptions when the required first-line drug is contraindicated, the patient previously failed it, or there is no evidence supporting its use in the patient's cancer type.

Minnesota Consumer Protections: Minnesota has some of the country's strongest consumer insurance protections, including requirements for timely Prior Authorization Denied: How to Appeal" class="auto-link">prior authorization decisions and detailed denial reason documentation.

Common Denial Reasons in Minnesota

• Immunotherapy: Checkpoint inhibitors like pembrolizumab and nivolumab are denied for off-label indications even when Mayo Clinic or University of Minnesota oncologists document strong evidence.
• Proton therapy: Mayo Clinic Rochester has an extensive proton therapy program, but insurers regularly deny proton therapy as "investigational" for certain cancer types.
• Genetic testing: Hereditary cancer gene panels and comprehensive tumor genomic profiling are denied despite established clinical guidelines.
• Targeted therapy: Prior authorization requirements delay access to precision oncology drugs matched to tumor mutations.
• Medical Assistance denials: Minnesota Medicaid enrollees with cancer face additional scrutiny through managed care organization prior authorization processes.

How to Appeal a Cancer Denial in Minnesota

Step 1 — Internal Appeal: File a written appeal within your plan's deadline, typically 180 days from the denial. Include your oncologist's medical necessity letter, NCCN guidelines, peer-reviewed literature, and Minnesota Statutes Section 62A.309 where applicable.

Step 2 — Expedited Internal Review: Request expedited processing when your oncologist certifies that delay would harm your health. Insurers must respond within 72 hours.

Step 3 — External Review via DOC: After exhausting internal appeals, file for external review through the Minnesota Department of Commerce. Call 651-539-1500 or visit mn.gov/commerce. IRO decisions are binding on the insurer.

Step 4 — Medical Assistance Fair Hearing: If you are on Minnesota Medical Assistance and your managed care plan denies cancer treatment, request a state fair hearing through the Minnesota Department of Human Services.

State and Community Resources

• Mayo Clinic Financial Counseling: Mayo Clinic offers financial counselors at Rochester and other Minnesota locations to help navigate insurance appeals.
• University of Minnesota Masonic Cancer Center Social Work: Social workers assist patients with insurance appeals and resource access.
• Minnesota Cancer Alliance: Statewide advocacy and patient resource network.
• American Cancer Society (ACS) Helpline: 1-800-227-2345, available 24/7 for Minnesota cancer patients needing insurance guidance, transportation, and local support.

Key Laws to Cite in Your Appeal

• Minnesota Statutes § 62A.309 (clinical trial routine cost coverage)
• Minnesota Statutes § 62A.3099 (oral chemotherapy parity)
• Minnesota Statutes § 62Q.73 (external review rights)
• Women's Health and Cancer Rights Act (federal)
• ACA Section 2719 (internal and external appeals)

Fight Back With ClaimBack

ClaimBack's free AI tool drafts a professional appeal letter in minutes, tailored to your insurer and denial reason. Don't let a denial be the final word.

Fight your denial at ClaimBack →

Related Reading:

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal